These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7120605)

  • 1. The clinical significance of clindamycin-resistant Bacteroides fragilis.
    Yee MH; Guiney DG; Hasegawa P; Davis CE
    JAMA; 1982 Oct; 248(15):1860-1. PubMed ID: 7120605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis.
    Tally FP; Snydman DR; Gorbach SL; Malamy MH
    J Infect Dis; 1979 Jan; 139(1):83-8. PubMed ID: 438530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clindamycin resistance in the Bacteroides fragilis group: association with hospital-acquired infections.
    Dalmau D; Cayouette M; Lamothe F; Vincelette J; Lachance N; Bourgault AM; Gaudreau C; Turgeon PL
    Clin Infect Dis; 1997 May; 24(5):874-7. PubMed ID: 9142785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
    Brook I
    Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of clindamycin resistance in the Bacteroides fragilis group.
    Reig M; Campello MG; Baquero F
    J Antimicrob Chemother; 1984 Dec; 14(6):595-603. PubMed ID: 6520060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to tetracycline, erythromycin, and clindamycin in the Bacteroides fragilis group: inducible versus constitutive tetracycline resistance.
    Privitera G; Fayolle F; Sebald M
    Antimicrob Agents Chemother; 1981 Sep; 20(3):314-20. PubMed ID: 7305321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infections caused by Bacteroides fragilis resistant to clindamycin: 2 further cases].
    Andrieu J; Kwantes M; Lapeyrere X; Gardon JD
    Nouv Presse Med; 1978 Feb; 7(7):571-2. PubMed ID: 643586
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic analysis of clindamycin resistance in Bacteroides species.
    Guiney DG; Hasegawa P; Stalker D; Davis CE
    J Infect Dis; 1983 Mar; 147(3):551-8. PubMed ID: 6833799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.
    Oteo J; Aracil B; Alós JI; Gómez-Garcés JL
    J Antimicrob Chemother; 2000 May; 45(5):691-3. PubMed ID: 10797095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteroides fragilis resistant to the administration of clindamycin.
    Salaki JS; Black R; Tally FP; Kislak JW
    Am J Med; 1976 Mar; 60(3):426-8. PubMed ID: 1258888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriological studies on Bacteroides fragilis infections and treatment with clindamycin for intravenous injection (author's transl)].
    Tomioka S; Kobayashi Y
    Jpn J Antibiot; 1977 Jan; 30(1):30-5. PubMed ID: 839641
    [No Abstract]   [Full Text] [Related]  

  • 16. Disc diffusion method to screen for high-level resistance to clindamycin and erythromycin in the Bacteroides fragilis group.
    Callihan DR; Nolte FS
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):131-7. PubMed ID: 3979019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin resistance transfer in Bacteroides fragilis.
    Teng LJ; Liaw SJ; Luh KT; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Nov; 27(4):186-95. PubMed ID: 9747348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis.
    Privitera G; Dublanchet A; Sebald M
    J Infect Dis; 1979 Jan; 139(1):97-101. PubMed ID: 108340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of clindamycin resistance in Bacteroides spp.
    Murray PR; Weber CJ
    J Clin Microbiol; 1983 Oct; 18(4):1001-2. PubMed ID: 6630454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased resistance of encapsulated Bacteroides fragilis to clindamycin.
    Brook I; Gillmore JD
    Chemotherapy; 1994; 40(1):16-20. PubMed ID: 8306810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.